Advertisement
Joining Mr. Senshan Yang, Chairman and Chief Executive Officer of ChinaMedicine Corporation, will be Mr. Richard Wu, Chief Financial Officer. TheCompany plans to make an earnings announcement prior to the call.
Advertisement
To participate in the live conference call, please dial the followingnumber five to ten minutes prior to the scheduled conference call time:1 866 800.8648. International callers should dial 1 617 614.2702, ConferencePasscode: 448 636 62.
If you are unable to participate in the call at this time, a replay willbe available for 14 days starting on Monday, November 16, at 12:00 p.m.Eastern Time. To access the replay, dial 888-286-8010, international callersdial 617-801-6888, and enter the passcode of 329 743 86.
About China Medicine Corporation
China Medicine Corporation is a developer and leading distributor ofprescription and over the counter ("OTC") drugs, traditional Chinese medicineproducts, herbs and dietary-supplements, medical devices, and medicalformulations in China. The Company also has its research and development forcefor certain products it manufactures through OEM arrangement and distributes.The Company distributes its products to wholesale distributors including morethan 300 hospitals and 500 medicine companies that sell to over 2,000 drugstores in 28 provinces throughout China. The Company actively develops anumber of proprietary products for a variety of uses, including oncology, highblood pressure and the removal of toxins from food and animal feeds. For moreinformation visit the Company's website at http://www.chinamedicinecorp.com .
Cautionary Statement
This press release contains forward-looking statements concerning theCompany's business and products. The Company's actual results may differmaterially depending on a number of risk factors including, but not limited to,the following: general economic and business conditions, the Company'sprojections of LifeTech's financial results in 2009 and 2010, obtainingregulatory approval for new products, the expected contribution of highermargin products, government support for rural health care, competition fromexisting and new competitors, changes in technology, and various other factorsbeyond its control. All forward-looking statements are expressly qualified intheir entirety by this Cautionary Statement and the risk factors detailed inthe Company's reports filed with the Securities and Exchange Commission. ChinaMedicine Corporation undertakes no duty to revise or update anyforward-looking statement to reflect events or circumstances after the date ofthis release.For more information, please contact: Company Contact: Mr. Richard P. Wu Chief Financial Officer China Medicine Corp. Tel: +86-20-8739-1718 Email: [email protected] Investor Relations Contact: Mr. Crocker Coulson, President CCG Investor Relations Tel: +1-646-213-1915 (NY Office) Email: [email protected] Web: http://www.ccgirasia.com
SOURCE China Medicine Corporation
